Tagged Articles

lymphoma 28 articles

EPA Sets New Rules for Cutting Emissions of Air Pollutants Such as Benzene

In a May press release, the Environmental Protection Agency (EPA) has announced official steps they are taking to reduce methane emissions from oil and gas sectors, from both new and already existing sources. In the oil and gas industries, the EPA has set new standards that will significantly reduce the methane, volatile organic compounds (VOC) such as benzene, and toxic air pollutants that come from new sources, or ones that have been modified or reconstructed. For the already existing sources, the EPA is issuing an Information Collection Request (ICR), which would require companies to submit information that would lead to methods to successfully ... Read More

Incidences of Blood Cancer are Significantly Higher Near Plants that Release Benzene

Non-Hodgkin lymphoma is a blood cancer that has been on the rise in the last few decades, likely due to the increase of industrial production throughout the U.S. Many refineries and plants release a chemical carcinogen called benzene that is linked to blood cancers such as non-Hodgkin lymphoma. Catherine Bulka, MPH, used data from the Environmental Protection Agency (EPA) U.S. Census Bureau to check patterns of non-Hodgkin lymphoma cases that occurred between 1999 and 2008 throughout the state of Georgia. She worked with Dr. Christopher Flowers his team in the Lymphoma Program at Emory University to analyze new cases of the blood cancer and the ... Read More

Nicole Kidman has ‘toxic’ breast implants removed

Australian actress Nicole Kidman had her breast implants removed as part of a new health regimen. “She doesn’t want anything that could be toxic inside her body,” a friend of Kidman’s told the National Enquirer. Thousands of women have opted to have their breast implants removed after questions have been raised about the safety of the implants. Some, including Real Housewives of Beverly Hills star Yolanda Foster, have gone public with devastating symptoms they claim were caused by their breast implants. Most women believe that saline-filled breast implants are safer than silicone-filled implants. However, both can cause adverse events. Even ... Read More

Many breast cancer patients don’t seek prompt treatment for drug-related heart failure

About 12 percent of breast cancer patients treated with chemotherapy drugs develop heart failure within three years after cancer treatment, but only a third saw a cardiologist within 90 days of the onset of symptoms, according to a new study. The research was presented at the American Cancer Society meeting in Baltimore. The study involved data from about 8,400 breast cancer patients age 65 and older who were treated either with chemotherapy drugs called anthracyclines, or a targeted therapy trastuzumab. Both drugs have been previously linked to heart problems. Researchers said that patients who saw a cardiologist were more likely ... Read More

Genetic mutation associated with cancer more likely in type 2 diabetics

People with a genetic abnormality associated with cancer are more likely to have type 2 diabetes, according to a new study published in the journal Nature Genetics. Type 2 diabetics are already at higher risk of developing cancer, especially blood cancers like lymphoma and leukemia. The new study suggests that gene mutations known as clonal mosaic events, or CMEs, may be source of the problem. CMEs occur when cells have extra copies or missing copies of DNA. They are rarely seen in younger people but are more likely to occur as people age. Previous research has shown that people with ... Read More

FDA panel considers benefits, risks of experimental rheumatoid arthritis drug

Drug regulators are questioning whether an experimental drug for rheumatoid arthritis has too great of a cancer risk and whether it actually works as well as the drug company claims. The drug, tofacitinib, marketed by Pfizer, is under review by a Food and Drug Administration (FDA) advisory panel, which will vote whether to recommend the treatment for FDA approval. The FDA isn’t required to follow the advice of its expert panels, but it usually does. Analysts have pegged tofacitinib as a potential blockbuster medication. “Blockbuster drugs” are ones that generate at least $1 billion in revenue for their owner over ... Read More

TNF blockers found to cause cancer in children

The Food and Drug Administration (FDA) announced today that it has completed its analysis on a class of arthritis drugs known as tumor necrosis factor (TNF) blockers and has concluded that there is an increased risk of lymphoma and other cancers associated with use of the drugs. The analysis first came to light in early June through an early communication by the FDA, and early last month the FDA said it would require the drug makers to add a stronger warning to the black box warning currently on the products, which warns of an increased risk of malignancies but does ... Read More

Arthritis drugs increase risk of cancer among children

The Food and Drug Administration (FDA) is requiring a group of popular arthritis drugs to include stronger warning of the increased risk of lymphoma and other cancers in children and adolescents treated with the medication. The warning, which follows an analysis by the FDA of tumor necrosis factor (TNF) blockers, will now be added to the black box warning currently on the products. The new safety information will add the warning of the occurrence of leukemia and new-onset psoriasis in patients treated with TNF blockers to the current black box warning on TNF blockers. Those medications currently contain a warning ... Read More